Other nonchemotherapeutic options for treatment of ER‐positive HER2‐positive advanced breast cancer include the combination of endocrine therapy plus anti‐HER2 therapy (single‐agent or dual blockade).10, 18. The gene discussed is ERBB2; the disease is breast cancer.